The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 31, 2023

Filed:

Aug. 10, 2018
Applicant:

Washington University, St. Louis, MO (US);

Inventors:

Shin-ichiro Imai, St. Louis, MO (US);

Alessia Grozio, St. Louis, MO (US);

Assignee:

Washington University, St. Louis, MO (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/706 (2006.01); A61P 3/04 (2006.01); A61K 45/06 (2006.01); A61K 48/00 (2006.01); C12N 15/86 (2006.01); G01N 33/50 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
A61K 31/706 (2013.01); A61K 45/06 (2013.01); A61K 48/005 (2013.01); A61P 3/04 (2018.01); C12N 15/86 (2013.01); G01N 33/5008 (2013.01); G01N 33/6803 (2013.01); C12N 2740/15032 (2013.01); C12N 2740/15043 (2013.01);
Abstract

Various methods and compositions for treating age-associated conditions and other medical conditions, such as muscle diseases, type 2 diabetes, and/or obesity are described. Methods of enhancing cellular uptake of NMN and stimulating NAD+ production are further described. Various mammalian cells and mammalian cell lines are described including those comprising a cDNA encoding a Slc12a8 protein. Gene therapy vectors comprising a nucleic acid encoding Slc12a8 and non-human animals comprising an inactivating mutation in a Slc12a8 gene are also disclosed. Also described are methods for screening a candidate compound to identify compounds that promote NMN transport.


Find Patent Forward Citations

Loading…